Neurocrine Biosciences Inc vs Unusual Machines Inc. Common Stock — how do they compare? Neurocrine Biosciences Inc trades at $136.25 (market cap $13.82B), while Unusual Machines Inc. Common Stock trades at $17 (market cap $885.73M). The key difference: Neurocrine Biosciences Inc is far larger — about 15.6× Unusual Machines Inc. Common Stock's market cap, and Unusual Machines Inc. Common Stock is trading nearer its 52-week high, Neurocrine Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Neurocrine Biosciences Inc for 24 Days and Unusual Machines Inc. Common Stock for 0 Days on average.
| NBIX | UMAC | |
|---|---|---|
Market Cap | $13.82B | $885.73M |
Volume | 1,506,669 | 3,688,533 |
Sector | Health | Technology |
52-Week High | $185.50 | $34.06 |
52-Week Low | $123.10 | $7.76 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $13.83B | $572.51M |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.
Read more on UMAC →